AAAAAA

   
Results: 1-10 |
Results: 10
GEMCITABINE(GEM)-CISPLATIN (CDDP) - A SCHEDULE FINDING PHASE I II STUDY/
Authors: KROEP JR PETERS GJ VANMOORSEL CJA VERMORKEN JB POSTMUS PE CATIK A PINEDO HM VANGROENINGEN CJ
Citation: Jr. Kroep et al., GEMCITABINE(GEM)-CISPLATIN (CDDP) - A SCHEDULE FINDING PHASE I II STUDY/, Annals of oncology, 9, 1998, pp. 608-608
MECHANISM(S) OF THE SCHEDULE-DEPENDENT INTERACTION BETWEEN GEMCITABINE (DFDC) AND CISPLATIN (CDDP) IN THE MURINE NONSMALL CELL LUNG (NSCL) TUMOR LEWIS LUNG
Authors: VANMOORSEL CJA VOORN DA VEERMAN G COMIJN EM SMID K VANDERVIJGH WJF POSTMUS PE VERMORKEN JB PINEDO HM PETERS GJ
Citation: Cja. Vanmoorsel et al., MECHANISM(S) OF THE SCHEDULE-DEPENDENT INTERACTION BETWEEN GEMCITABINE (DFDC) AND CISPLATIN (CDDP) IN THE MURINE NONSMALL CELL LUNG (NSCL) TUMOR LEWIS LUNG, Annals of oncology, 9, 1998, pp. 187-187
GEMCITABINE (GEM) AND PACLITAXEL (TAX) - PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS IN PATIENTS WITH NONSMALL CELL LUNG-CANCER (NSCLC)
Authors: KROEP JR VOORN DA GIACCONE G POSTMUS PE VANMOORSEL CJA BEIJNEN JH ROSING H LOVES WJP SMIT EF GALL H VANGROENINGEN CJ PINEDO HM PETERS GJ
Citation: Jr. Kroep et al., GEMCITABINE (GEM) AND PACLITAXEL (TAX) - PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS IN PATIENTS WITH NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 374-374
GEMCITABINE-CISPLATIN COMBINATIONS IN SOLID TUMORS - A SCHEDULE FINDING, PHASE I II CLINICAL-STUDY/
Authors: KROEP JR PETERS GJ VANMOORSEL CJA CATIK A VERMORKEN JB PINEDO HM VANGROENINGEN CJ
Citation: Jr. Kroep et al., GEMCITABINE-CISPLATIN COMBINATIONS IN SOLID TUMORS - A SCHEDULE FINDING, PHASE I II CLINICAL-STUDY/, Annals of oncology, 9, 1998, pp. 498-498
TOMUDEX AND CISPLATIN HAVE ADDITIVE CYTOTOXICITY AND NO BIOCHEMICAL INTERACTION IN OVARIAN-CANCER CELL-LINES
Authors: ACKLAND S GARG M VANMOORSEL CJA KUIPER CM SMID K PETERS GJ
Citation: S. Ackland et al., TOMUDEX AND CISPLATIN HAVE ADDITIVE CYTOTOXICITY AND NO BIOCHEMICAL INTERACTION IN OVARIAN-CANCER CELL-LINES, Annals of oncology, 9, 1998, pp. 593-593
COMBINATION CHEMOTHERAPY STUDIES WITH GEMCITABINE
Authors: VANMOORSEL CJA VEERMAN G BERGMAN AM GUECHEV A VERMORKEN JB POSTMUS PE PETERS GJ
Citation: Cja. Vanmoorsel et al., COMBINATION CHEMOTHERAPY STUDIES WITH GEMCITABINE, Seminars in oncology, 24(2), 1997, pp. 17-23
PRECLINICAL COMBINATION THERAPY WITH GEMCITABINE AND MECHANISMS OF RESISTANCE
Authors: PETERS GJ VANHAPEREN VWTR BERGMAN AM VEERMAN G SMITSKAMPWILMS E VANMOORSEL CJA KUIPER CM BRAAKHUIS BJM
Citation: Gj. Peters et al., PRECLINICAL COMBINATION THERAPY WITH GEMCITABINE AND MECHANISMS OF RESISTANCE, Seminars in oncology, 23(5), 1996, pp. 16-24
VITAMIN-A AND BETA-CAROTENE INFLUENCE THE LEVEL OF BENZO[A]PYRENE-INDUCED DNA-ADDUCTS AND DNA-REPAIR ACTIVITIES IN HAMSTER TRACHEAL EPITHELIUM IN ORGAN-CULTURE
Authors: WOLTERBEEK APM ROGGEBAND R VANMOORSEL CJA BAAN RA KOEMAN JH FERON VJ RUTTEN AAJJL
Citation: Apm. Wolterbeek et al., VITAMIN-A AND BETA-CAROTENE INFLUENCE THE LEVEL OF BENZO[A]PYRENE-INDUCED DNA-ADDUCTS AND DNA-REPAIR ACTIVITIES IN HAMSTER TRACHEAL EPITHELIUM IN ORGAN-CULTURE, Cancer letters, 91(2), 1995, pp. 205-214
AN INTEGRATED PHYSICAL MAP OF 210 MARKERS ASSIGNED TO THE SHORT ARM OF HUMAN-CHROMOSOME-11
Authors: REDEKER E HOOVERS JMN ALDERS M VANMOORSEL CJA IVENS AC GREGORY S KALIKIN L BLIEK J DEGALAN L VANDENBOGAARD R VISSER J VANDERVOORT R FEINBERG AP LITTLE PFR WESTERVELD A MANNENS M
Citation: E. Redeker et al., AN INTEGRATED PHYSICAL MAP OF 210 MARKERS ASSIGNED TO THE SHORT ARM OF HUMAN-CHROMOSOME-11, Genomics, 21(3), 1994, pp. 538-550
TAQI AND RSAI POLYMORPHISMS IN THE H19 GENE (D11S813E)
Authors: REDEKER E VANMOORSEL CJA FEINBERG A MANNENS M
Citation: E. Redeker et al., TAQI AND RSAI POLYMORPHISMS IN THE H19 GENE (D11S813E), Human molecular genetics, 2(6), 1993, pp. 823-823
Risultati: 1-10 |